Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Loeb

Showing results (311-320 of 355) with videos related to

Pageof 36
Sort By:
Plos One|December 3, 2015
Using Exclusion-Based Sample Preparation (ESP) to Reduce Viral Load Assay CostScott M Berry, Hannah M Pezzi, Eram D Williams, et al.
Cancer|June 29, 2016
Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNAMasanori Hayashi, David Chu, Christian F Meyer, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|April 10, 2014
Standardization in patient safety: the WHO High 5s projectAgnès Leotsakos, Hao Zheng, Rick Croteau, et al.
Ecology and Evolution|August 8, 2020
Seasonal polyphenism of spotted-wing <i>Drosophila</i> is affected by variation in local abiotic conditions within its invaded range, likely influencing survival and regional population dynamicsDara G Stockton, Anna K Wallingford, Gabrielle Brind'amore, et al.
Infection Control and Hospital Epidemiology|March 10, 2001
Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conferenceM Loeb, D W Bentley, S Bradley, et al.
International Journal of Cancer|February 6, 2013
A dose-finding study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomaK A Thornton, A R Chen, M M Trucco, et al.
Clinical Sarcoma Research|November 10, 2018
A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomasMatteo M Trucco, Christian F Meyer, Katherine A Thornton, et al.
Pediatric Blood & Cancer|September 15, 2017
Consensus and controversies regarding the treatment of rhabdomyosarcomaScott C Borinstein, Diana Steppan, Masanori Hayashi, et al.
Plos One|July 15, 2015
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk SarcomasXin Huang, Haein Park, Joseph Greene, et al.
Health Affairs (Project Hope)|April 9, 2009
Reducing health care hazards: lessons from the commercial aviation safety teamPeter J Pronovost, Christine A Goeschel, Kyle L Olsen, et al.
Pageof 36

Showing results (311-320 of 355) with videos related to

Sort By:
Pageof 36
Plos One|December 3, 2015
Using Exclusion-Based Sample Preparation (ESP) to Reduce Viral Load Assay CostScott M Berry, Hannah M Pezzi, Eram D Williams, et al.
Cancer|June 29, 2016
Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNAMasanori Hayashi, David Chu, Christian F Meyer, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|April 10, 2014
Standardization in patient safety: the WHO High 5s projectAgnès Leotsakos, Hao Zheng, Rick Croteau, et al.
Ecology and Evolution|August 8, 2020
Seasonal polyphenism of spotted-wing <i>Drosophila</i> is affected by variation in local abiotic conditions within its invaded range, likely influencing survival and regional population dynamicsDara G Stockton, Anna K Wallingford, Gabrielle Brind'amore, et al.
Infection Control and Hospital Epidemiology|March 10, 2001
Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conferenceM Loeb, D W Bentley, S Bradley, et al.
International Journal of Cancer|February 6, 2013
A dose-finding study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomaK A Thornton, A R Chen, M M Trucco, et al.
Clinical Sarcoma Research|November 10, 2018
A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomasMatteo M Trucco, Christian F Meyer, Katherine A Thornton, et al.
Pediatric Blood & Cancer|September 15, 2017
Consensus and controversies regarding the treatment of rhabdomyosarcomaScott C Borinstein, Diana Steppan, Masanori Hayashi, et al.
Plos One|July 15, 2015
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk SarcomasXin Huang, Haein Park, Joseph Greene, et al.
Health Affairs (Project Hope)|April 9, 2009
Reducing health care hazards: lessons from the commercial aviation safety teamPeter J Pronovost, Christine A Goeschel, Kyle L Olsen, et al.
Pageof 36